Key Facts
>2,500 rare disease patients recruited since October 2018 93% consent rate for data to be used in future research Study localized to 9 countries, spanning the US, Canada, Europe, and Japan
Company details
Solutions
Delivering advanced patient care
Driving insights and analysis
Specialism
Digitally-enabled out of hospital care
Drug discovery and Clinical trials
Company details
Want to connect with this innovator?
Make an enquiryWebsite
vitaccess.com/Markets already exporting to
Clients are based in France, Belgium and the US. Real-wolrd evidence studies with patients participating in the Belgium, Canada, France, Germany, Italy, Japan, Spain, UK, US
Desired Markets
Europe, North America and Japan
Desired customer types
Biopharmaceuticals